Click
Drag
NTHRYS WHATSAPP
NTHRYS LOGO Welcome Interface Environment Research Products Academics About Contact
NTHRYS LOGO

Biochemistry Summer Internship

Info
Fees and Application Process
Testimonials
FAQs
Placements
Updates

Identification of Key Metabolic Enzymes Differentiating Cancer Cell Metabolism
+
This objective focuses on uncovering specific enzymes that are pivotal in the metabolic pathways of cancer cells, which differ from those in normal cells. Understanding these differences can lead to the development of targeted cancer therapies.

Research Methodology

Phase 1: Preliminary Data Collection

  1. Conduct a literature review to identify previously studied metabolic enzymes associated with cancer.
  2. Use bioinformatics tools to analyze genetic expression databases for cancer-specific metabolic activity.

Phase 2: Experimental Validation

  1. Design and implement in vitro experiments to observe enzyme activity in cancer vs. normal cell lines.
  2. Utilize CRISPR-Cas9 gene editing to manipulate enzyme expression in cell lines and measure metabolic outcomes.

Phase 3: Clinical Correlation

  1. Analyze patient tissue samples to correlate enzyme levels with clinical outcomes in cancer progression.
  2. Develop enzyme inhibition assays to evaluate the therapeutic potential of targeting these enzymes in clinical trials.

Research Approach

  1. Multidisciplinary collaboration between biochemists, geneticists, and oncologists.
  2. Integration of computational modeling and experimental biology to validate findings.

Protocols

  1. Standard operating procedures for genetic sequencing and analysis.
  2. Guidelines for conducting CRISPR experiments in compliance with ethical standards.
  3. Protocols for enzyme activity assays and inhibitor testing.
Elucidation of the Role of Mitochondrial Dysfunction in Cancer Progression and Aging
+
This objective seeks to understand how mitochondrial dysfunction influences the progression of cancer and the aging process. Insights from this research could lead to breakthroughs in mitigating age-related diseases and cancer.

Research Methodology

Phase 1: Identification and Analysis

  1. Review existing literature on mitochondrial dysfunction related to aging and cancer.
  2. Employ bioinformatics to identify mitochondrial genes altered in cancer and aging.

Phase 2: Functional Studies

  1. Use in vitro models to study the effects of mitochondrial mutations on cellular metabolism.
  2. Apply advanced imaging techniques to observe mitochondrial dynamics in live cells.

Phase 3: Interventional Strategies

  1. Test compounds that can enhance mitochondrial function in pathological models.
  2. Assess the therapeutic effects of these compounds in animal models.

Research Approach

  1. Interdisciplinary approach involving molecular biology, genetics, and pharmacology.
  2. Utilize cutting-edge technology such as CRISPR and high-resolution microscopy.

Protocols

  1. Protocols for mitochondrial DNA extraction and sequencing.
  2. Standard procedures for cell culture and compound testing.
  3. Guidelines for the ethical use of animal models in research.
Characterization of Metabolic Reprogramming in Senescence and Its Implications for Aging and Cancer
+
This objective aims to characterize the changes in metabolic pathways during cellular senescence and understand how these changes contribute to aging and cancer. The insights could provide potential targets for therapeutic interventions.

Research Methodology

Phase 1: Mapping Senescence-Associated Metabolic Changes

  1. Conduct a comprehensive metabolic profiling of senescent cells using mass spectrometry and NMR spectroscopy.
  2. Compare metabolic profiles with non-senescent cells to identify key metabolic shifts.

Phase 2: Molecular Mechanisms

  1. Investigate the regulatory mechanisms controlling these metabolic shifts using genomic and proteomic approaches.
  2. Utilize gene editing tools to modulate key genes involved in metabolic reprogramming.

Phase 3: Testing Therapeutic Interventions

  1. Develop and test small molecule inhibitors that can modify senescent cell metabolism.
  2. Evaluate the efficacy of these inhibitors in delaying aging or preventing cancer progression in model organisms.

Research Approach

  1. Combining cellular biology, biochemistry, and systems biology to explore metabolic reprogramming.
  2. Collaboration with computational biologists to analyze data and model metabolic pathways.

Protocols

  1. Detailed protocols for metabolic profiling and data analysis.
  2. Guidelines for the use of CRISPR/Cas9 in targeted gene editing.
  3. Protocols for the development and testing of pharmacological agents in cell culture and animal models.
Investigation of the Role of Autophagy in the Metabolism of Aging Cells and Cancer Cells
+
This objective investigates how autophagy, a critical cellular process for degrading and recycling cellular components, affects the metabolism of aging and cancer cells. The goal is to elucidate potential therapeutic targets within the autophagic pathways.

Research Methodology

Phase 1: Baseline Autophagic Activity Assessment

  1. Measure autophagic flux in aging and cancer cells using fluorescent microscopy and biochemical assays.
  2. Compare these measurements with those from young and healthy cells to identify significant deviations.

Phase 2: Manipulation of Autophagy

  1. Utilize genetic modification techniques like siRNA and CRISPR-Cas9 to enhance or suppress autophagy in targeted cell lines.
  2. Assess the metabolic and phenotypic changes in these cells.

Phase 3: Evaluation of Therapeutic Potentials

  1. Test pharmacological agents that modulate autophagy in cell lines and animal models.
  2. Study the effects of these agents on cellular metabolism, aging markers, and tumorigenic potential.

Research Approach

  1. Integrated use of cellular biology, molecular biology, and pharmacology to explore autophagy.
  2. Collaboration across research labs to pool expertise in imaging, genetics, and compound screening.

Protocols

  1. Standard protocols for assessing autophagic activity, including the use of LC3-II and p62 as markers.
  2. Detailed procedures for genetic manipulation and drug treatment in vitro and in vivo.
  3. Guidelines for ethical considerations in animal experimentation.
Development of Targeted Therapies to Manipulate Metabolic Pathways Specific to Cancerous Cells Without Affecting Normal Cells
+
This objective focuses on creating selective therapeutic agents that target metabolic pathways uniquely active in cancer cells, aiming to minimize side effects on normal cells. This approach could lead to more effective and safer cancer treatments.

Research Methodology

Phase 1: Target Identification

  1. Identify and validate metabolic enzymes or pathways that are upregulated in cancer cells through genomic and proteomic studies.
  2. Perform comparative analyses between cancerous and normal cells using high-throughput screening.

Phase 2: Drug Development

  1. Design and synthesize small molecules or biologics that can specifically inhibit the identified targets.
  2. Test these agents in vitro using cancer cell lines and in vivo in animal models to assess specificity and efficacy.

Phase 3: Clinical Trials

  1. Conduct early-stage clinical trials to evaluate safety and metabolic impacts on human subjects.
  2. Advance to later stages to confirm therapeutic benefits and monitor long-term effects.

Research Approach

  1. Use a multidisciplinary approach involving molecular biology, pharmacology, and clinical research.
  2. Collaborate with pharmaceutical companies for drug development and testing.

Protocols

  1. Protocols for target validation including gene expression profiling and enzymatic assays.
  2. Standard operating procedures for drug synthesis and toxicity testing.
  3. Clinical trial protocols adhering to international regulatory standards.
Analysis of the Interplay Between Dietary Nutrients and Metabolic Pathways Influencing Both Aging and Cancer
+
This objective aims to explore how dietary nutrients affect the metabolic pathways that play a role in aging and cancer development. Understanding these interactions may lead to dietary recommendations that could prevent or mitigate these conditions.

Research Methodology

Phase 1: Nutrient Profiling

  1. Identify key nutrients and their typical intake levels in various populations.
  2. Analyze existing data on nutrient impact on metabolic pathways related to aging and cancer.

Phase 2: Experimental Studies

  1. Conduct controlled in vitro and in vivo experiments to study specific nutrient interactions with cellular metabolism in models of aging and cancer.
  2. Use metabolomics and genomics to understand how these nutrients influence gene expression and enzyme activity.

Phase 3: Longitudinal and Epidemiological Studies

  1. Engage in longitudinal cohort studies to observe the effects of dietary patterns on aging and cancer incidence over time.
  2. Analyze epidemiological data to correlate dietary intake with aging and cancer trends globally.

Research Approach

  1. Interdisciplinary collaboration involving nutritional science, biochemistry, and epidemiology.
  2. Application of advanced analytical techniques like next-generation sequencing and high-throughput metabolomic profiling.

Protocols

  1. Standard operating procedures for dietary assessment and nutrient analysis.
  2. Protocols for in vitro and in vivo experimental setups.
  3. Ethical guidelines for conducting human and animal studies.
Study of Epigenetic Changes in Metabolic Genes During Aging and Cancer Progression
+
This objective focuses on understanding how epigenetic modifications (such as DNA methylation and histone modification) affect metabolic genes in the context of aging and cancer. Insights from this research could reveal new mechanisms of disease progression and potential targets for intervention.

Research Methodology

Phase 1: Identification of Epigenetic Markers

  1. Conduct genome-wide assays to identify epigenetic changes in metabolic genes associated with aging and cancer.
  2. Analyze these changes using next-generation sequencing technologies to map the epigenetic landscape.

Phase 2: Functional Characterization

  1. Employ CRISPR/dCas9 technology to specifically alter epigenetic marks on target genes and assess the metabolic impact.
  2. Use cellular assays to measure changes in metabolic activity and cell viability.

Phase 3: Therapeutic Intervention

  1. Develop and test epigenetic drugs that can reverse harmful epigenetic modifications.
  2. Evaluate the efficacy of these drugs in pre-clinical models of aging and cancer.

Research Approach

  1. Integrate molecular biology, genetics, and pharmacology to dissect and manipulate epigenetic modifications.
  2. Collaborative efforts with computational biologists to analyze large-scale epigenetic data sets.

Protocols

  1. Detailed protocols for epigenetic profiling, including specific techniques for DNA methylation and histone modification analysis.
  2. Guidelines for using CRISPR technology in targeted epigenetic editing.
  3. Standardized procedures for the development and testing of epigenetic therapeutic agents.
Exploration of the Role of Microbiome Alterations in the Metabolic Pathways Related to Aging and Cancer
+
This objective seeks to uncover how changes in the microbiome influence metabolic pathways that affect aging and cancer progression. Research in this area could lead to microbiome-targeted therapies and preventative strategies.

Research Methodology

Phase 1: Microbiome Profiling

  1. Collect microbiome samples from diverse populations at different ages and cancer stages.
  2. Use high-throughput sequencing to analyze microbial composition and function.

Phase 2: Functional Studies

  1. Conduct in vitro and in vivo experiments to study the impact of specific microbiome alterations on metabolic pathways.
  2. Use metabolomics to trace the biochemical outputs of microbial activity and its effects on the host.

Phase 3: Intervention Development

  1. Identify and test prebiotics, probiotics, and synbiotics that can modify the microbiome to prevent or mitigate aging and cancer.
  2. Evaluate these interventions in clinical trials for their efficacy and safety.

Research Approach

  1. Utilize a multidisciplinary approach incorporating microbiology, genomics, and clinical research.
  2. Collaborate with nutritional scientists to understand the dietary impacts on microbiome composition.

Protocols

  1. Standard protocols for microbial sampling, DNA extraction, and sequencing.
  2. Guidelines for conducting controlled dietary intervention studies in humans and animals.
  3. Protocols for the ethical conduct of human clinical trials involving microbiome manipulation.
Mapping of Cellular Metabolism in Aging Tissues to Identify New Biomarkers for Early Detection of Cancer
+
This objective aims to map the changes in cellular metabolism that occur in aging tissues and determine how these changes could serve as biomarkers for the early detection of cancer. This research could improve early diagnostic strategies and potentially increase survival rates.

Research Methodology

Phase 1: Metabolic Profiling

  1. Collect tissue samples from aging populations and perform comprehensive metabolic profiling using techniques such as mass spectrometry and NMR spectroscopy.
  2. Analyze data to identify metabolic signatures that are predictive of cancer development.

Phase 2: Validation

  1. Use bioinformatic tools to cross-validate identified metabolic markers with existing cancer biomarkers.
  2. Conduct longitudinal studies to track the progression of these markers in individuals over time.

Phase 3: Clinical Application

  1. Develop non-invasive tests based on identified metabolic biomarkers for early cancer detection.
  2. Collaborate with clinical laboratories to implement these tests in routine screenings.

Research Approach

  1. Integrate metabolomics, bioinformatics, and clinical research to explore metabolic changes in aging tissues.
  2. Partner with geriatric healthcare providers and oncologists to facilitate sample collection and clinical trial design.

Protocols

  1. Protocols for safe and ethical tissue sampling from aging populations.
  2. Standard operating procedures for metabolic profiling and data analysis.
  3. Guidelines for the development and clinical validation of diagnostic tests.
Investigation of the Impact of Cellular Stress Responses on Metabolic Pathways in Aging and Cancer
+
This objective examines how cellular stress responses, such as oxidative stress and DNA damage response, influence metabolic pathways in aging and cancer cells. Understanding these pathways could lead to new treatments that target these stress responses to improve health outcomes in aging populations and cancer patients.

Research Methodology

Phase 1: Stress Induction and Monitoring

  1. Induce stress responses in cultured aging and cancer cells using chemical agents or physical stressors.
  2. Monitor changes in metabolic activity using real-time imaging and metabolic flux analysis.

Phase 2: Molecular Analysis

  1. Analyze changes in gene expression and protein activity related to stress response pathways using transcriptomics and proteomics.
  2. Identify potential therapeutic targets by mapping the interaction networks between stress responses and metabolic pathways.

Phase 3: Therapeutic Testing and Development

  1. Design and synthesize inhibitors or modulators for the identified targets.
  2. Test these therapeutic agents in cell models and animal models to evaluate efficacy and safety.

Research Approach

  1. Utilize a combination of cell biology, molecular biology, and bioinformatics to dissect the effects of stress responses on metabolism.
  2. Engage in interdisciplinary collaborations with pharmacologists and clinical researchers to translate findings into therapeutic strategies.

Protocols

  1. Protocols for inducing and monitoring cellular stress in vitro and in vivo.
  2. Standard operating procedures for transcriptomic and proteomic analyses.
  3. Clinical trial protocols for testing new therapeutic agents.

Note: NTHRYS currently operates through three registered entities: NTHRYS BIOTECH LABS (NBL), NTHRYS OPC PVT LTD (NOPC), and NTHRYS Project Greenshield (NPGS).

NTHRYS CONSORTIUM

NBL NOPC NPGS
Updates
Industrial

Basic

Academic

Terms | Refund and Cancellations | Privacy Policy | Shipping Policy | Retruns Policy
Website Designed, Programmed and Maintained
by
Balaji S Rao


Web

Chat
Contact

Us
Download

PDF
Placements